What is NDC 51407-701?

51407-701 is the product NDC for Aprepitant, Aprepitant 40 mg/1 capsule, listed with the FDA by Golden State Medical Supply, Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.

Golden State Medical Supply, Inc., NDC labeler code 51407. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Aprepitant?

19 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Aprepitant NDC 51407-701 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)51407-701Labeler and product segments. Claims need a package NDC.

Product NDC at billing width51407-0701Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
51407-701-01	5140707010151407070101	1 BLISTER PACK in 1 CARTON (51407-701-01) / 1 CAPSULE in 1 BLISTER PACK (51407-701-11)Marketed from Jun 11, 2025
51407-701-05	5140707010551407070105	5 BLISTER PACK in 1 CARTON (51407-701-05) / 1 CAPSULE in 1 BLISTER PACK (51407-701-11)Marketed from Jun 11, 2025

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Aprepitant
Generic name (nonproprietary): aprepitant
Active ingredients: Aprepitant — 40 mg/1
Dosage form: Capsule
Route: Oral
Labeler: Golden State Medical Supply, Inc.NDC labeler code 51407
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 211835
Marketing start: Oct 21, 2020
Listing expires: Dec 31, 2027
Other FDA classes: Cytochrome P450 2C9 Inducers (Mechanism)Cytochrome P450 3A4 Inducers (Mechanism)Cytochrome P450 3A4 Inhibitors (Mechanism)Neurokinin 1 Antagonists (Mechanism)
Identifiers: Product ID 51407-701_4c9db5a6-88e7-5f5a-e063-6294a90acb0eSPL ID 4c9db5a6-88e7-5f5a-e063-6294a90acb0eSPL set ID 377c3ecb-fdec-dde4-e063-6294a90a29bdRxCUI 403810, 403811, 644088, 754508UNII 1NF15YR6UYUPC 0351407703064, 0351407704030, 0351407702067, 0351407701053
Pharmacologic class: Substance P/Neurokinin-1 Receptor Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N451407070101 followed by a unit qualifier and the quantity

Package 51407-0701-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Mar 9, 2026.

Indications (excerpt from the label)

Aprepitant is a substance P/neurokinin 1 (NK1) receptor antagonist. Aprepitant capsules are indicated • in combination with other antiemetic agents, in patients 12 years of age and older for prevention of: o acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy (HEC) including high-dose cisplatin ( 1.1 ) o nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy (MEC) ( 1.1 ) • for prevention of postoperative nausea and vomiting (PONV) in adults ( 1.2 ) Limitations of Use : ( 1.3 ) • Aprepitant has not been studied for treatment of established nausea and vomiting. • Chronic …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 51407-701

What is NDC 51407-701?: 51407-701 is the product NDC for Aprepitant, Aprepitant 40 mg/1 capsule, listed with the FDA by Golden State Medical Supply, Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Aprepitant.
What is the active ingredient?: Aprepitant.
Who is the labeler?: Golden State Medical Supply, Inc., NDC labeler code 51407. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Aprepitant?: 19 other product NDCs are listed under this name. See all Aprepitant NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Aprepitant NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Aprepitant	Aprepitant 125 mg/1	CapsuleOral	BluePoint Laboratories	68001-668	68001-0668-19
Aprepitant	—	Kit	BluePoint Laboratories	68001-669	68001-0669-15
Aprepitant	Aprepitant 40 mg/1	CapsuleOral	BluePoint Laboratories	68001-666	68001-0666-0168001-0666-17
Aprepitant	Aprepitant 80 mg/1	CapsuleOral	BluePoint Laboratories	68001-667	68001-0667-0168001-0667-19
Aprepitant	Aprepitant 40 mg/1	CapsuleOral	Torrent Pharmaceuticals Limited	13668-591	13668-0591-8113668-0591-82
Aprepitant	Aprepitant 80 mg/1	CapsuleOral	Torrent Pharmaceuticals Limited	13668-592	13668-0592-8413668-0592-86
Aprepitant	Aprepitant 125 mg/1	CapsuleOral	Torrent Pharmaceuticals Limited	13668-593	13668-0593-86
Aprepitant	—	Kit	Torrent Pharmaceuticals Limited	13668-594	13668-0594-87
Aprepitant	Aprepitant 80 mg/1	CapsuleOral	Golden State Medical Supply, Inc.	51407-702	51407-0702-0251407-0702-06
Aprepitant	Aprepitant 125 mg/1	CapsuleOral	Golden State Medical Supply, Inc.	51407-703	51407-0703-06

All 20 Aprepitant NDCs

Other NDCs under ANDA 211835

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 211835
Product	Strength	Form · route	Labeler	Product NDC
Aprepitant	Aprepitant 40 mg/1	CapsuleOral	Torrent Pharmaceuticals Limited	13668-591
Aprepitant	Aprepitant 80 mg/1	CapsuleOral	Torrent Pharmaceuticals Limited	13668-592
Aprepitant	Aprepitant 125 mg/1	CapsuleOral	Torrent Pharmaceuticals Limited	13668-593
Aprepitant	—	Kit	Torrent Pharmaceuticals Limited	13668-594
Aprepitant	Aprepitant 80 mg/1	CapsuleOral	Golden State Medical Supply, Inc.	51407-702
Aprepitant	Aprepitant 125 mg/1	CapsuleOral	Golden State Medical Supply, Inc.	51407-703
Aprepitant	—	Kit	Golden State Medical Supply, Inc.	51407-704